By John Pappas

Whether it is triggered by a whistleblower’s tip related to Foreign Corrupt Practices Act compliance, suspicions of deceptive sales and marketing practices, or hints of trade secret or other intellectual property theft, a regulatory investigation is nothing any pharmaceutical or medical device company wants. It allows the investigating agency to open a sweeping investigation that can encompass a company’s entire document repository, draining an incredible amount of the company’s time and resources.

Read Full Article (PDF)


Phone: 303.824.0900 | Toll Free: 877.557.4273
Fax: 303.293.9073
Privacy Policy | Privacy Shield


OpenText™, The Information Company, is a market leader in Enterprise Information Management software and solutions, enabling Intelligent and Connected Enterprises by managing, leveraging, securing and gaining insight into enterprise information, on-premises or in the cloud. OpenText™ Catalyst designs, hosts and supports the world’s fastest and most powerful document repositories for large-scale discovery and regulatory compliance. For more than 20 years, global corporations and their counsel have relied on Catalyst to help reduce litigation costs and take control of complex legal matters.

Copyright © 2019 Catalyst Repository Systems. All Rights Reserved.